BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2018

Dec 19, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2018-12-14

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-19	Common Stock	G	160	—	Disposed	182041	Indirect
2018-11-20	Common Stock	G	540	—	Disposed	181501	Indirect
2018-12-14	Common Stock	M	2000	$17.86	Acquired	290290	Direct
2018-12-14	Common Stock	S	2000	$92.64	Disposed	288290	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-12-14	Stock Option (Right to buy Common Stock)	$17.86	M	2000	Disposed	2018-12-16	Common Stock (2000)	Direct

Footnotes

F1: On November 19, 2018, the reporting entity gifted 160 shares to an educational institution.

F2: On November 20, 2018, the reporting entity gifted 540 shares to a non-profit organization.

F3: Trade made pursuant to a 10b5-1 plan executed on May 21, 2018.

F4: Reflects the number of options outstanding after the transactions from this specific stock option grant.